Michael Saylor Tokenization Could Enable a Free Market for Yield Challenging Traditional Banking
Ford Faces Potential European Setback Except for One Key Segment
Anchorage Consumer Price Index Pushes Higher in April 2026 Reflecting Persistent Regional Inflation
SpaceXs Potential SP Sector Classification A Multifaceted Challenge
Equities Close Higher as Technology and Healthcare Lead SP 500 Adds 062
UK Exports to US Plunge 25 Following Trumps Liberation Day Tariff Surge
VNDA Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results
DSGR Q1 2026 Earnings EPS Beats Estimates Despite Modest Stock Decline
CRCT Q1 2026 Earnings Earnings Per Share Surges Past Estimates by 145
RHP Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Group Demand
FCX Q1 2026 Earnings EPS Surges Past Estimates Amid Copper Price Strength
CIEN Q1 2026 Earnings Strong EPS Beat Despite Revenue Uncertainty
Kiniksa Pharmaceuticals Holds Steady Near 54 as Stock Tests Key Resistance Levels
MindWalk Holdings Corp HYFT Climbs 468 Testing Key Resistance at 188
Independence Realty Trust IRT Slips 130 as Apartment REIT Faces Sector Pressure
IRIDEX Corporation IRIX Holds Steady at 101 as Key Support and Resistance Levels Tighten
Carlyle Credit Income Fund CCIF Hovers Near Support Amid Modest Decline
California Toxic Leak Emergency May Disrupt Chemical Supply Chains
CTOS Q1 2026 Earnings EPS Misses Estimates as Company Navigates Operational Challenges
Synaptics SYNA Edges Higher Testing Key Resistance Zone
EE Q1 2026 Earnings EPS Misses Estimates Yet Shares Rise on Steady Operations
CYPH Q3 2025 Earnings Narrowed Loss Exceeds Expectations Shares Fall Despite EPS Surprise
WesBanco Inc Depositary Shares WSBCO Q1 2026 Earnings EPS Beats Estimates Preferred Shares Slip
MGNX Q1 2026 Earnings Narrowed Loss Meets Street Views Amid Pipeline Progress
CNO Financial Group Q1 2026 Earnings Strong Earnings Beat Fails to Lift Shares
Hyliion Holdings Corp HYLN Q1 2026 Earnings Narrowed Loss Surprises Market Stock Surges Over 42
BiomX Inc PHGE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline